Infertility Treatment Market Worth $2.2 Billion by 2023 - Exclusive Report by MarketsandMarkets™

Tuesday, November 6, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

CHICAGO, November 6, 2018 /PRNewswire/ --

According to the new market research report "Infertility Treatment Market

 by Product (Equipment, Media, Accessories), Procedure [ART (IVF, ICSI, Surrogate), Insemination, Laparoscopy, Tubal Ligation], Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Cryobanks) - Forecasts to 2023", published
by MarketsandMarkets™, the global Infertility Treatment Market is expected to reach USD 2.2 billion by 2023 from USD 1.5 billion in 2018, at a CAGR of 8.0%.

     (Logo: )

Don't miss out on business opportunities in Infertility Treatment Market. Speak to our analyst and gain crucial industry insights that will help your business grow:

The major factors driving the growth of the Infertility Treatment Market include declining global fertility rate; rising number of fertility clinics worldwide; technological advancements; and increasing public- private investments, funds, and grants.

The equipment segment is expected to account for the largest share of the products market in 2018 

On the basis of product, the Infertility Treatment Market is segmented into equipment, media & consumables, and accessories. The equipment segment is further categorized into incubators, micromanipulator systems, imaging & laser systems, ovum aspiration pumps, sperm analyzers, incubators, microscopes, cryosystems, and gas analyzers. The equipment segment is expected to command the largest share of the global Infertility Treatment Market in 2018. This is primarily due to the development of new and advanced infertility treatment systems by key market players and increase in the use of these devices in IVF laboratories worldwide.

Browse and in-depth TOC on "Infertility Treatment Market"  

106 - Tables 

32 - Figures  

176 - Pages  

View more detailed TOC @

Assisted reproductive technology is expected to grow at the highest CAGR in the global Infertility Treatment Market during the forecast period 

Based on procedure, the global Infertility Treatment Market is classified into assisted reproductive technology (ART), artificial insemination (AI), fertility surgery, and other infertility treatment procedures. The ART segment is expected to grow at the highest CAGR during the forecast period of 2018 to 2023. The large share of this segment can be attributed to ongoing technological advancements in the field of ART, growing awareness about IVF among individuals, and increasing adoption of surrogacy by single parents and same-sex couples.

Asia Pacific is expected to dominate the Infertility Treatment Market during the forecast period 

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific is expected to account for the largest share of the global Infertility Treatment Market during the forecast period (2018-2023). The large share of this market can be attributed to the rise in medical tourism in Asian countries, rapid increase in healthcare expenditure, and declining fertility rates in these countries, thereby propelling the growth of the Infertility Treatment Market in Asia Pacific.

Request for Free Sample Report @

The major players operating in the Infertility Treatment Market include The Cooper Companies Inc.  (US), Cook Group Incorporated (US), Vitrolife AB (Sweden), Thermo Fisher Scientific, Inc. (US) Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), Irvine Scientific (US), The Baker Company, Inc. (US), and Kitazato (Japan) among others.

Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : +1-888-600-6441 Email:

Research Insight:

Visit Our Website:

SOURCE MarketsandMarkets

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store